Latest news with #SIReporterNewDelhi
&w=3840&q=100)
Business Standard
5 days ago
- Business
- Business Standard
Here's why Angel One share price is buzzing in trade on Thursday, June 5
Angel One shares were in demand after announcing the May 2025 business update. The company's client base surged 23.83 per cent Y-o-Y to 31.95 million in May 2025, as against 23.83 million in May 2024 Angel One share price today SI Reporter New Delhi Angel One share price: Angel One shares were buzzing in trade on Thursday, June 5, 2025, with the stock rising up to 3.83 per cent to hit an intraday high of ₹3,249 per share. At 12:50 PM, Angel One shares continued to trade near day's high, up 3.38 per cent at ₹3,234.95 per share. In comparison, BSE Sensex was trading 0.76 per cent higher at 81,616.69 levels. What drove Angel One shares higher today? Angel One shares were in demand after announcing the May 2025 business update. The company's client base surged 23.83 per cent year-on-year (Y-o-Y) to 31.95 million in May 2025, as against 23.83 million in the same month last year (May 2024). Its average client funding book zoomed 46.2 per cent Y-o-Y to ₹4,005 crore in May 2025, from ₹2,740 crore in May 2024. The company's unique MFs SIP registered grew 32.8 per cent annually to 6,28,280 in May 2025, from 4,73,220 in May 2024. Angel One's cash average daily turnover (ADTO) rose 4.2 per cent annually to ₹8,600 crore, from ₹8,300 crore a year ago. Its Commodity ADTO climbed 47.2 per cent Y-o-Y to ₹74,500 crore in May 2025, from ₹50,600 crore in May 2024. The Cash Turnover Market Share also expanded 91 basis points (bps) to 18 per cent in May 2025, from 17.1 per cent in May 2024. However, gross client acquisition fell 43.1 per cent to 0.50 million in May 2025, from 0.88 million in May 2024. Average daily orders dropped 23.4 per cent annually to 5.79 million in May 2025, from 7.56 million in May 2024. It, however, surged 3.2 per cent month-on-month (M-o-M) from 5.61 million. Catch Stock Market Updates Today LIVE Angel One Q4 results The company's total revenue from operations dropped 22.1 per cent Y-o-Y to ₹1,056 crore, as against ₹1,357.3 crore a year ago. Profit after tax (PAT) plunged 48.7 per cent Y-o-Y to ₹174.5 crore in Q4FY25, from ₹399.9 crore in Q4FY24. At the operating level, earnings before interest, tax, depreciation and amortisation (Ebitda) plummeted 44 per cent annually to ₹264.3 crore in Q4FY25, from ₹475.5 crore in Q4FY24. Angel One's net broking revenue fell around 28 per cent to ₹490.6 crore as against ₹685.6 crore in the March 2024 quarter. Angel One dividend Angel One's board of directors approved and recommended a final dividend of ₹26 per share for FY25. About Angel One Established in 1996, Angel One (formerly Angel Broking) is among the leading retail stockbroking and financial services firms in India, founded and chaired by Dinesh Thakkar. The company provides a broad suite of offerings, including equities, derivatives, mutual funds, insurance, and personal loans. As of March 2024, Angel One serves a client base of 3.1 crore, with total assets under management (AUM) exceeding ₹3,700 crore.
&w=3840&q=100)
Business Standard
03-06-2025
- Business
- Business Standard
₹534-crore order lifts Transrail Lighting share price 6% on Tuesday, June 3
The uptick in Transrail Lighting share price came after the company announced that it has secured orders worth Rs 534 crore. SI Reporter New Delhi Transrail Lighting share price: Transrail Lighting shares were buzzing in trade in a weak market on Tuesday, June 3, 2025, with the scrip rallying up to 5.86 per cent to hit an intraday high of ₹675.85 per share. By 10:20 AM, Transrail Lighting share was off day's high, and was trading 2.32 per cent higher at 653.20 per share. In comparison, BSE Sensex was trading 0.24 per cent lower at 81,179.95 levels. Why did Transrail Lighting share price jump in trade today? The uptick in Transrail Lighting share price came after the company announced that it has secured orders worth Rs 534 crore. In an exchange filing, Transrail Lighting said, 'Transrail Lighting,, a prominent EPC player in the Transmission & Distribution (T&D) segment, with presence in Civil, Railways, and Poles & Lighting, wins fresh orders of ₹534 crore across domestic and international geographies.' On securing the deal, Randeep Narang, MD & CEO of Transrail Lighting, said, 'We are pleased to begin the new financial year with a steady build-up in order inflows, led by wins in our core Transmission & Distribution segment. These new orders also include our biggest substation job which we are going to execute in Africa. With FY26 order intake already crossing ₹1,600 crore, we remain focused on efficient execution and timely delivery.' About Transrail Lighting Transrail Lighting is among the leading engineering, procurement, and construction (EPC) companies with a strong focus on the power transmission and distribution (T&D) sector. The company brings over four decades of industry expertise and operates globally, with a presence in 59 countries across five continents. It delivers end-to-end turnkey solutions, encompassing design, engineering, supply, manufacturing, construction, and testing services. Its diverse business verticals include Power T&D, Civil Construction, Railways, Poles & Lighting, and Solar EPC, supported by a team of more than 2,100 employees. In the Power T&D segment, Transrail Lighting operates large-scale manufacturing facilities in India, producing Galvanized Lattice Towers, Overhead Conductors, and Galvanised Monopoles. These facilities are complemented by a state-of-the-art, accredited tower testing facility, ensuring the highest standards of quality and performance.
&w=3840&q=100)
Business Standard
02-06-2025
- Business
- Business Standard
Niva Bupa share price drops 11% in trade on Monday, June 2; here's why
Niva Bupa share price fell on the back of a huge block deal. As soon as the market opened, 198.30 million or 10.85 per cent of total equity of Niva Bupa at ₹82.4 worth ₹1,634 cr changed hands on BSE SI Reporter New Delhi Niva Bupa share price: Health insurance company Niva Bupa share price was under pressure on the first trading day of June i.e. Monday, June 2, 2025, with the stock dropping up to 11.14 per cent to an intraday low of ₹82 per share. At 9:54 AM, Niva Bupa share price was trading 9.73 per cent lower at ₹83.30. In comparison, BSE Sesex was trading 0.75 per cent lower at 80,840.11 levels. Why did Niva Bupa shares drop in trade today? Niva Bupa share price fell on the back of a huge block deal. As soon as the market opened, 198.30 million or 10.85 per cent of total equity of Niva Bupa at ₹82.4 worth about ₹1,634 crore changed hands on BSE. By 10:01 AM, 232.73 million shares worth ₹1,919.84 crore had changed hands on BSE. According to reports, Fettle Tone and Krishnan Ramchandra were likely to offload a 7.2 per cent stake in Niva Bupa Health Insurance Company Ltd. Niva Bupa Q4 results Niva Bupa Health Insurance Company's consolidated profit after tax (PAT) rose 31 per cent year-on-year (Y-o-Y) to ₹206 crore in Q4FY25, from ₹157 crore in the same period last year (Q4FY24). Gross premiums written rose 18 per cent to ₹2,078.65 crore, compared to ₹1,759 crore in Q4FY24. Net premium income for the quarter stood at ₹1,672.11 crore, up from ₹1,152.43 crore a year earlier. Net income from investments came in at ₹93.78 crore during the quarter, compared to ₹67.91 crore in the year-ago period. The company's solvency ratio improved to 3.03 in FY25 from 2.55 in FY24, indicating strong financial health and an enhanced ability to meet long-term obligations. About Niva Bupa Niva Bupa Health Insurance Company is one of India's leading standalone health insurers, formed as a joint venture between Bupa, a global leader in healthcare services, and Fettle Tone LLP, an affiliate of True North Fund VI LLP, a prominent Indian private equity firm. The company is dedicated exclusively to health insurance, offering a diverse portfolio of plans tailored for individuals, families, and senior citizens. With a focus on delivering accessible and high-quality healthcare, Niva Bupa combines global expertise with a deep understanding of the Indian market. The company provides a comprehensive suite of services including hospitalisation cover, day-care treatments, outpatient care, and maternity and senior citizen plans. It boasts a robust network of over 8,700 hospitals for cashless claims and offers added conveniences like unlimited teleconsultation and 24/7 digital support through its health app and Insta Assist platform. With a widespread distribution network across 350 cities and partnerships with over 35,000 bank branches, Niva Bupa continues to strengthen its presence in the health insurance sector while prioritising customer-centric service and innovation.
&w=3840&q=100)
Business Standard
22-05-2025
- Business
- Business Standard
Here's why Nalco share price was buzzing in trade on May 22; details
Nalco shares surged after the company reported its highest-ever net profit and revenue from operations since inception in FY25. SI Reporter New Delhi Nalco share price: National Aluminium Company Limited (Nalco) shares were in demand on Thursday, May 22, 2025, with the scrip rising up to 5.50 per cent to hit an intraday high of ₹191.65 apiece. However, at 10:03 AM, Nalco shares were off highs, and were trading 1.60 per cent higher at ₹184.55 per share. In comparison, BSE Sensex was trading 0.76 per cent lower at 80,973.03 level. Why did Nalco share price rise? Nalco shares surged after the company reported its highest-ever net profit and revenue from operations since inception in FY25. Nalco posted a record net profit of ₹5,325 crore, marking a 158 per cent increase year-on-year (Y-o-Y). The company also reported its highest-ever revenue from operations, reaching ₹16,788 crore for the fiscal year. For the fourth quarter ended March 2025, the company registered a net profit of ₹2,078 crore, a major rise from ₹1,016 crore in the same quarter last year — an increase of 105 per cent. Quarterly revenue also witnessed robust growth, climbing to ₹5,268 crore from ₹3,579 crore a year ago. The strong performance was fueled by strong aluminium and alumina prices, streamlined operations, and enhanced operational efficiency. Nalco also benefitted from sustained momentum in its expansion projects and healthy margins across business segments. Operationally, the company achieved its highest-ever bauxite excavation at 76.48 lakh tonnes and recorded all-time high domestic metal sales of 4.55 lakh tonnes. CMD Brijendra Pratap Singh noted that the company's growth gained momentum in the latter half of the fiscal year. 'This is clearly reflected in our robust financial performance and strong revenue growth. Enhancing efficiency, optimising costs, and the unwavering commitment of our employees have played a key role in maintaining competitiveness in a dynamic market,' he said. Singh further stressed upon Nalco's strategic focus on process improvements and a performance-driven culture, which has helped build a motivated and efficient workforce. These efforts have enabled the company to sustain growth even amid market volatility. Looking ahead, NALCO remains committed to long-term, sustainable growth through several strategic initiatives. These include the 5th Stream expansion of the Alumina Refinery, the operationalization of the Pottangi Bauxite Mines, and the expansion of the existing Smelter Plant and Captive Power Plant. These projects are expected to strengthen the company's foundation and reinforce its position in the global aluminium sector. About Nalco Nalco is a premier public sector enterprise under the Ministry of Mines, Government of India, with a 51.28 per cent government stake. Established on January 7, 1981, and headquartered in Bhubaneswar, Odisha, Nalco is renowned for its fully integrated operations spanning bauxite mining, alumina refining, aluminium smelting, and power generation. As a Navratna company since April 28, 2008, Nalco has emerged as a key player in India's aluminium industry, contributing significantly to the country's self-reliance in this critical sector. The company operates major facilities including the Panchpatmali Bauxite Mines and Alumina Refinery in Koraput district, and an Aluminium Smelter and Captive Power Plant in Angul, Odisha.
&w=3840&q=100)
Business Standard
20-05-2025
- Business
- Business Standard
Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25
Pfizer shares climbed after the company reported a strong set of March quarter results on May 19, 2025. SI Reporter New Delhi Pfizer share price: Shares of Pfizer were in demand on Tuesday, May 20, 2025, with the scrip rallying up to 11.33 per cent to an intraday high of ₹4,970.40 per share. What is the reason behind the rally in Pfizer share price? Pfizer shares climbed after the company reported a strong set of March quarter results on May 19, 2025. The company's profit soared 85 per cent year-on-year (Y-o-Y) to ₹331 crore in the March quarter of FY25, from ₹179 crore in the March quarter of FY24. Pfizer's revenue from operations rose 8.3 per cent Y-o-Y to ₹591.9 crore in Q4FY25, from ₹546.6 crore in Q4FY24. At the operating level, earnings before interest, tax, depreciation and amortisation (Ebitda) climbed 20.1 per cent annually to ₹227.5 crore in March quarter of FY25, from ₹189.43 crore in the March quarter of FY24. Pfizer dividend The Board of Directors has recommended a final dividend of ₹35 per equity share of ₹10 each (350 per cent) and a special dividend of ₹100 per equity share of ₹10 each (1000 per cent) in view of 75th year of Pfizer in India and a special dividend of ₹30 per equity share of ₹10 each (300 per cent) in view of the gain on transfer of assignment of leasehold land and building constructed on such land thereon, totaling to a dividend of ₹165 per equity share ₹10 each (1650 per cent) for FY25. Moreover, the company has fixed July 9, 2025, as the Record Date for determining entitlement of Members to final dividend for the financial year ended March 31, 2025. About Pfizer Pfizer is a globally recognised biopharmaceutical company with a legacy spanning more than 170 years. Headquartered in New York City, the company is dedicated to discovering, developing, and delivering medical breakthroughs that improve lives. With operations in over 125 countries, Pfizer plays a critical role in advancing global health through a diverse range of innovative treatments and vaccines. In India, Pfizer has a strong presence, including a state-of-the-art manufacturing facility in Goa that supports both local and international supply chains. ALSO READ | The company's work spans key therapeutic areas such as vaccines, oncology, internal medicine, and rare diseases. Pfizer is a leader in vaccine development, notably using mRNA technology in its COVID-19 vaccine. Its oncology division focuses on cutting-edge cancer treatments, while internal medicine offerings address chronic conditions like diabetes and heart disease. Pfizer also invests in rare disease research and provides popular over-the-counter products like Advil, Nexium, Centrum, and ChapStick.
